EUVIMEDEUVIMED entdecken
Crossref

Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer

Helin Zhang, Xingxing Zhang, Yuelin Zhang, Dali Han, Hualan Ha, Biao Zhang, Panfeng Shang

Molecular Biotechnology · 2025

DOI: 10.1007/s12033-024-01149-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Helin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital & Clinical Medical School, Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, No. 82 Cui Ying Gate, Che…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Biomarkers, Tumor, Kinesins, Neoplasms. Die Arbeit nennt 30 Literaturangaben. Gefördert von: This work was supported by the Medical Innovation and Development Project of Lanzhou University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

KIFC2 plays an important role in prostate cancer progression and chemotherapy resistance, but the mechanism of its involvement in other malignancies remains unclear. Therefore, this study aimed to analyze and validate the mechanism of effect of KIFC2 in multiple tumors. Bioinformatic analysis was performed in conjunction with multiple databases (The Cancer Genome Atlas, Genotype-Tissue Expression Project, Human Protein Atlas, etc.) to fully explore the potential role of KIFC2 within individual tumors and to analyze the correlation with major research components such as prognosis, mutations, and the tumor microenvironment. The expression of KIFC2 demonstrates a significant correlation with the prognosis, clinical phenotype, tumor mutational burden, microsatellite instability, and tumor microenvironment across various malignancies and is associated with the modulation of diverse functional and signaling pathways. The differences in the expression of KIFC2 in the bladder cancer tissues (14 pairs) were statistically significant. The pan-cancer analysis in this study revealed the multifunctionality of KIFC2 in a variety of tumors, indicating a possible prognostic predictor and potential therapeutic target for tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsBiomarkers, TumorKinesinsNeoplasmsHumansPrognosisTumor MicroenvironmentGene Expression Regulation, NeoplasticComputational BiologyMicrosatellite InstabilityMutationMaleFemale

Stichwörter der Autor:innen

Bladder cancerKIFC2Pan-CancerPrognosisTumor microenvironment

Substanzen

Biomarkers, TumorKinesins

Autor:innen und Institutionen

  • The Second Hospital & Clinical Medical School, Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, No. 82 Cui Ying Gate, Cheng Guan District, Lanzhou, 730030, Gansu, China.
  • The Second Hospital & Clinical Medical School, Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, No. 82 Cui Ying Gate, Cheng Guan District, Lanzhou, 730030, Gansu, China. shangpf@lzu.edu.cn.

Förderung

  • This work was supported by the Medical Innovation and Development Project of Lanzhou University

Zitieren

APA

Zhang, H., Zhang, X., Zhang, Y., Han, D., Ha, H., Zhang, B., & Shang, P. (2025). Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01149-y

Vancouver

Zhang H, Zhang X, Zhang Y, Han D, Ha H, Zhang B, et al. Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01149-y

BibTeX
@article{Zhang2025,
  author = {Zhang, Helin and Zhang, Xingxing and Zhang, Yuelin and Han, Dali and Ha, Hualan and Zhang, Biao and Shang, Panfeng},
  title = {Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer},
  journal = {Molecular Biotechnology},
  year = {2025},
  doi = {10.1007/s12033-024-01149-y}
}
Kostenlos starten →